Literature DB >> 22670128

Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.

Klaus Görlinger1, Dietmar Fries, Daniel Dirkmann, Christian F Weber, Alexander A Hanke, Herbert Schöchl.   

Abstract

BACKGROUND: Massive bleeding and transfusion of packed red blood cells (PRBC), fresh frozen plasma (FFP) and platelets are associated with increased morbidity, mortality and costs. PATIENTS AND METHODS: We analysed the transfusion requirements after implementation of point-of-care (POC) coagulation management algorithms based on early, calculated, goal-directed therapy with fibrinogen concentrate and prothrombin complex concentrate (PCC) in different perioperative settings (trauma surgery, visceral and transplant surgery (VTS), cardiovascular surgery (CVS) and general and surgical intensive care medicine) at 3 different hospitals (AUVA Trauma Centre Salzburg, University Hospital Innsbruck and University Hospital Essen) in 2 different countries (Austria and Germany).
RESULTS: In all institutions, the implementation of POC coagulation management algorithms was associated with a reduction in the transfusion requirements for FFP by about 90% (Salzburg 94%, Innsbruck 88% and Essen 93%). Furthermore, PRBC transfusion was reduced by 8.4-62%. The incidence of intraoperative massive transfusion (≥10 U PRBC) could be more than halved in VTS and CVS (2.56 vs. 0.88%; p < 0.0001 and 2.50 vs. 1.06%; p = 0.0007, respectively). Platelet transfusion could be reduced by 21-72%, except in CVS where it increased by 115% due to a 5-fold increase in patients with dual antiplatelet therapy (2.7 vs. 13.7%; p < 0.0001).
CONCLUSIONS: The implementation of perioperative POC coagulation management algorithms based on early, calculated, goal-directed therapy with fibrinogen concentrate and PCC is associated with a reduction in the transfusion requirements for FFP, PRBC and platelets as well as with a reduced incidence of massive transfusion. Thus, the limited blood resources can be used more efficiently.

Entities:  

Year:  2012        PMID: 22670128      PMCID: PMC3364099          DOI: 10.1159/000337186

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  94 in total

1.  Excessive perioperative bleeding: are fibrin monomers and factor XIII the missing link?

Authors:  Donat R Spahn; Lars M Asmis
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

2.  Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study.

Authors:  Andrew J Westbrook; Jodi Olsen; Michael Bailey; John Bates; Michael Scully; Robert F Salamonsen
Journal:  Heart Lung Circ       Date:  2008-12-31       Impact factor: 2.975

3.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Authors:  Kathryn A O'Connell; Jennifer J Wood; Robert P Wise; Jay N Lozier; M Miles Braun
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

4.  Activity-based costs of blood transfusions in surgical patients at four hospitals.

Authors:  Aryeh Shander; Axel Hofmann; Sherri Ozawa; Oliver M Theusinger; Hans Gombotz; Donat R Spahn
Journal:  Transfusion       Date:  2009-12-09       Impact factor: 3.157

5.  [Coagulation management in trauma-related massive bleeding. - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI)].

Authors:  Dietmar Fries; Petra Innerhofer; Peter Perger; Manfred Gütl; Sabine Heil; Nikolaus Hofmann; Werner Kneifel; Ludwig Neuner; Thomas Pernerstorfer; Georg Pfanner; Herbert Schöchl; Bernhard Ziegler; Camillo Kölblinger; Sibylle Kozek-Langenecker
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2010-09-13       Impact factor: 0.698

6.  Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients.

Authors:  Kenji Inaba; Bernardino C Branco; Peter Rhee; John B Holcomb; Lorne H Blackbourne; Ira Shulman; Janice Nelson; Demetrios Demetriades
Journal:  Arch Surg       Date:  2010-09

7.  Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.

Authors:  A H Glenngård; U Persson; C Söderman
Journal:  Transfus Med       Date:  2005-08       Impact factor: 2.019

8.  Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury.

Authors:  Ilona T A Pereboom; Marieke T de Boer; Elizabeth B Haagsma; Herman G D Hendriks; Ton Lisman; Robert J Porte
Journal:  Anesth Analg       Date:  2009-04       Impact factor: 5.108

9.  Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel.

Authors:  Lawrence Ang; Vachaspathi Palakodeti; Ahmer Khalid; Sotirios Tsimikas; Zaheib Idrees; Phillip Tran; Paul Clopton; Nayab Zafar; Guilherme Bromberg-Marin; Shahin Keramati; Ehtisham Mahmud
Journal:  J Am Coll Cardiol       Date:  2008-09-23       Impact factor: 24.094

10.  Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study.

Authors:  Pierre Toulon; Yves Ozier; Annick Ankri; Marie-Hélène Fléron; Geneviève Leroux; Charles Marc Samama
Journal:  Thromb Haemost       Date:  2009-02       Impact factor: 5.249

View more
  43 in total

1.  Patient Blood Management: Clinical Hemotherapy and Hemostasis Management in Perioperative Settings.

Authors:  Klaus Görlinger; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2012-04       Impact factor: 3.747

Review 2.  Reducing transfusion requirements in liver transplantation.

Authors:  Ciara I Donohue; Susan V Mallett
Journal:  World J Transplant       Date:  2015-12-24

Review 3.  The pathophysiology, diagnosis and treatment of the acute coagulopathy of trauma and shock: a literature review.

Authors:  J Kaczynski; M Wilczynska; L Fligelstone; J Hilton
Journal:  Eur J Trauma Emerg Surg       Date:  2013-12-12       Impact factor: 3.693

Review 4.  [Rotational thromboelastometry for the diagnosis of coagulation disorders].

Authors:  M Honickel; O Grottke
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-07-12       Impact factor: 0.840

Review 5.  [Modern coagulation management in bleeding trauma patients : Point-of-care guided administration of coagulation factor concentrates and hemostatic agents].

Authors:  Marc Maegele
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-28       Impact factor: 0.840

6.  Introduction of thromboelastometry-guided administration of fresh-frozen plasma is associated with decreased allogeneic blood transfusions and post-operative blood loss in cardiopulmonary-bypass surgery.

Authors:  Junko Ichikawa; Takahito Marubuchi; Keiko Nishiyama; Mitsuharu Kodaka; Klaus Görlinger; Makoto Ozaki; Makiko Komori
Journal:  Blood Transfus       Date:  2017-03-23       Impact factor: 3.443

Review 7.  [Viscoelasticity-based treatment of bleeding injuries].

Authors:  Marc Maegele; Michael Caspers; Herbert Schöchl
Journal:  Unfallchirurg       Date:  2017-09       Impact factor: 1.000

8.  Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.

Authors:  Michael P Chapman; Ernest E Moore; Christopher R Ramos; Arsen Ghasabyan; Jeffrey N Harr; Theresa L Chin; John R Stringham; Angela Sauaia; Christopher C Silliman; Anirban Banerjee
Journal:  J Trauma Acute Care Surg       Date:  2013-12       Impact factor: 3.313

9.  Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study.

Authors:  Francesco Vasques; Luca Spiezia; Alberto Manfrini; Vincenzo Tarzia; Dario Fichera; Paolo Simioni; Gino Gerosa; Carlo Ori; Guido Di Gregorio
Journal:  J Anesth       Date:  2016-10-18       Impact factor: 2.078

10.  A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings.

Authors:  Elisa A Ferrante; Kiev R Blasier; Thomas B Givens; Cynthia A Lloyd; Timothy J Fischer; Francesco Viola
Journal:  Anesth Analg       Date:  2016-12       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.